Sheng Hu
3PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Nov 28, 2024
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study.Caicun Zhou, Gongyan Chen, Yunchao Huang
|Feb 22, 2024
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trial.Shengxiang Ren, Xicheng Wang, Bao-Hui Han
|Jul 14, 2023
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung Cancer.Tao Jiang, Qiqi Jin, Jiahao Wang
Pageof 1
Frequent Collaborators
3 joint publications
Ying Cheng
2 joint publications
Caicun Zhou
2 joint publications
Yongqian Shu
1 joint publications
Tao Jiang
1 joint publications
Qiqi Jin
1 joint publications
Jiahao Wang
1 joint publications
Hongmei Zhang
1 joint publications
Jian Chen
1 joint publications
Gongyan Chen
1 joint publications
Yunchao Huang
